Who has invested in Phosplatin Therapeutics?

Adinvest AG are named among the investors backing Phosplatin Therapeutics.

Phosplatin Therapeutics Funding: $74M Raised, Series A

Phosplatin Therapeutics funding overview

Phosplatin Therapeutics is based in New York City. Phosplatin Therapeutics has raised $74M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in December 2021. The round record for Phosplatin Therapeutics runs through 2021; nothing later has been disclosed. Investors on record include Adinvest AG.

Phosplatin Therapeutics at a glance

Total raised: $74M
Latest round: Series A
Latest round date: December 2021
Headquarters: New York City
Notable investors: Adinvest AG

Frequently asked about Phosplatin Therapeutics funding

How much has Phosplatin Therapeutics raised?: Phosplatin Therapeutics has raised $74M in total disclosed funding across the rounds on record.
Who has invested in Phosplatin Therapeutics?: Adinvest AG are named among the investors backing Phosplatin Therapeutics.
What was the latest Phosplatin Therapeutics funding round?: The most recent disclosed round is a Series A, announced in December 2021.
Where is Phosplatin Therapeutics based?: Phosplatin Therapeutics is based in New York City.
When did Phosplatin Therapeutics last raise?: The last disclosed Phosplatin Therapeutics round closed in December 2021 at Series A.

Phosplatin Therapeutics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in New York City below to benchmark round size and investor mix.

Phosplatin Therapeutics Funding: $74M Raised, Series A

Phosplatin Therapeutics funding overview

Phosplatin Therapeutics at a glance

Frequently asked about Phosplatin Therapeutics funding

Companies related to Phosplatin Therapeutics (18)

Browse related funding lists (3)